COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century?

Author(s): Alessia Catalano*

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 1 , Issue 1 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

The ongoing Coronavirus disease 2019 (COVID-19) outbreak in China has become the world's leading health headline and is causing major panic and public concerns. After emerging in the City of Wuhan, China, COVID-19 has spread to several countries becoming a worldwide pandemia. Among the studies on COVID-19, it has been demonstrated that novel coronavirus pneumonia is closely associated with inflammatory storms. Controlling the inflammatory response may be as important as targeting the virus. Irisin is a muscle-contraction-induced immunomodulatory myokine related to physical activity. Irisin drives the “browning” of white adipocytes, so enhancing metabolic uncoupling and hence caloric expenditure. Irisin has been clearly shown to be a handyman molecule by exerting beneficial effects on adipose tissues, pancreas, and bone through “cross-talk” between skeletal muscleadipocyte, skeletal muscle-pancreas, and skeletal muscle-bone, respectively. Irisin has been proposed as a promising strategy for early diagnosis and treatment of various types of cancers, neurological diseases and inflammatory conditions. Irisin has been demonstrated to suppress the immune response, too. The importance of irisin is demonstrated by the increase in the number of scientific papers and patents in recent years. The identification of irisin receptor should greatly facilitate the understanding of irisin’s function in exercise and human health. This review examines the structure and recent advances in activities of irisin, suggesting it for further studies on the prevention and cure of COVID-19. Nowadays, studies on irisin plasma levels and physical activity may be useful tools to further investigate the prevention of COVID-19. Irisin may be suggested as a potential novel intervention for COVID-19 by mitigating inflammatory storms, suppressing the immune response and simultaneously alleviating neurological disorders such as depression and anxiety.

Keywords: Irisin, browning, diabetes, myokine, cross-talk, osteoporosis.

[1]
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[2]
Wang H, Wang Z, Dong Y, et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Cell Discov 2020; 6(1): 10.
[http://dx.doi.org/10.1038/s41421-020-0148-0] [PMID: 32133152]
[3]
Pedersen MG, Meneghini M. Quantifying undetected COVID-19 cases and effects of containment measures in Italy 2020. ResearchGate Preprint 2020.
[5]
Bedford J, Enria D, Giesecke J, et al. COVID-19: towards controlling of a pandemic. Lancet 2020; 395(10229): 1015-8.
[http://dx.doi.org/10.1016/S0140-6736(20)30673-5] [PMID: 32197103]
[6]
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020; 19(3): 149-50.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[7]
Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 2020; 6(3): 315-31.
[http://dx.doi.org/10.1021/acscentsci.0c00272] [PMID: 32226821]
[8]
Guo YR, Cao QD, Hong ZS. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res 2020; 7(1): 1-10.
[http://dx.doi.org/10.1186/s40779-020-00240-0] [PMID: 31928528]
[9]
Gonçalves-Sá J. In the fight against the new coronavirus outbreak, we must also struggle with human bias. Nat Med 2020; 26(3): 305.
[http://dx.doi.org/10.1038/s41591-020-0802-y] [PMID: 32152585]
[10]
Cohen J, Kupferschmidt K. Countries test tactics in ‘war’ against COVID-19. Science 2020; 367(6484): 1287-8.
[http://dx.doi.org/10.1126/science.367.6484.1287] [PMID: 32193299]
[11]
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[12]
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020; 20(6): 363-74.
[http://dx.doi.org/10.1038/s41577-020-0311-8] [PMID: 32346093]
[13]
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229): 1033-4.
[http://dx.doi.org/10.1016/S0140-6736(20)30628-0] [PMID: 32192578]
[14]
Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020; 27(5): 1451-4.
[http://dx.doi.org/10.1038/s41418-020-0530-3] [PMID: 32205856]
[15]
Chen P, Mao L, Nassis GP. Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions. J Sport Health Sci 2020; 9(2): 103-4.
[http://dx.doi.org/10.1016/j.jshs.2020.02.001] [PMID: 32099716]
[16]
McTiernan A, Friedenreich CM, Katzmarzyk PT, et al. 2018 Physical activity guidelines advisory committee*. Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc 2019; 51(6): 1252-61.
[http://dx.doi.org/10.1249/MSS.0000000000001937] [PMID: 31095082]
[17]
Currier D, Lindner R, Spittal MJ, Cvetkovski S, Pirkis J, English DR. Physical activity and depression in men: Increased activity duration and intensity associated with lower likelihood of current depression. J Affect Disord 2020; 260: 426-31.
[http://dx.doi.org/10.1016/j.jad.2019.09.061] [PMID: 31539676]
[18]
Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481(7382): 463-8.
[http://dx.doi.org/10.1038/nature10777] [PMID: 22237023]
[19]
Halling JF, Jessen H, Nøhr-Meldgaard J, et al. PGC-1α regulates mitochondrial properties beyond biogenesis with aging and exercise training. Am J Physiol Endocrinol Metab 2019; 317(3): E513-25.
[http://dx.doi.org/10.1152/ajpendo.00059.2019] [PMID: 31265325]
[20]
Kelly DP. Medicine. Irisin, light my fire. Science 2012; 336(6077): 42-3.
[http://dx.doi.org/10.1126/science.1221688] [PMID: 22491843]
[21]
Colaianni G, Sanesi L, Storlino G, Brunetti G, Colucci S, Grano M. Irisin and bone: From preclinical studies to the evaluation of its circulating levels in different populations of human subjects. Cells 2019; 8(5) E451
[http://dx.doi.org/10.3390/cells8050451] [PMID: 31091695]
[22]
Anastasilakis AD, Polyzos SA, Makras P, Douni E, Mantzoros CS. Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor? Metabolism 2019; 93: 100-2.
[http://dx.doi.org/10.1016/j.metabol.2019.01.013] [PMID: 30690037]
[23]
Albrecht E, Schering L, Buck F, et al. Irisin: Still chasing shadows. Mol Metab 2020; 34: 124-35.
[http://dx.doi.org/10.1016/j.molmet.2020.01.016] [PMID: 32180552]
[24]
Elsen M, Raschke S, Eckel J. Browning of white fat: does irisin play a role in humans? J Endocrinol 2014; 222(1): R25-38.
[http://dx.doi.org/10.1530/JOE-14-0189] [PMID: 24781257]
[25]
Askari H, Rajani SF, Poorebrahim M, Haghi-Aminjan H, Raeis-Abdollahi E, Abdollahi M. A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review. Pharmacol Res 2018; 129: 44-55.
[http://dx.doi.org/10.1016/j.phrs.2018.01.012] [PMID: 29414191]
[26]
Narayanan SA, Metzger CE, Bloomfield SA, Zawieja DC. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J 2018; 32(9): 4848-61.
[http://dx.doi.org/10.1096/fj.201800178R] [PMID: 29596023]
[27]
Mahgoub MO, D’Souza C, Al Darmaki RSMH, Baniyas MMYH, Adeghate E. An update on the role of irisin in the regulation of endocrine and metabolic functions. Peptides 2018; 104: 15-23.
[http://dx.doi.org/10.1016/j.peptides.2018.03.018] [PMID: 29608940]
[28]
Giorgino F, Natalicchio A, Marrano N. Pharmacological use of a myokine able to preserve the function and mass of the pancreatic cells under dysmetabolic conditions US Patent No 10,413,596 2019.
[29]
Grano M, Colaianni G, Cuscito C. Irisin for care and prevention of osteoporosis US Patent 2017/0028018 A1 2017.
[30]
Kim H, Wrann CD, Jedrychowski M. Irisin mediates effects on bone via αV integrin receptors. FASEB J 2019.
[http://dx.doi.org/10.1016/j.cell.2019.06.028]
[31]
Kim H, Wrann CD, Jedrychowski M, et al. Irisin mediates effects on bone and fat via αV integrin receptors. Cell 2018; 175(7): 1756-1768.e17.
[http://dx.doi.org/10.1016/j.cell.2018.10.025] [PMID: 30550785]
[32]
Kim H, Wrann CD, Jedrychowski M, et al. Irisin mediates effects on bone and fat via αV integrin receptors. Cell 2019; 178(2): 507-8.
[http://dx.doi.org/10.1016/j.cell.2019.06.028] [PMID: 31299203]
[33]
Greenhill C. Irisin receptor in osteocytes identified. Nat Rev Endocrinol 2019; 15(2): 63.
[http://dx.doi.org/10.1038/s41574-018-0151-9] [PMID: 30602738]
[34]
Korta P, Pocheć E, Mazur-Biały A. Irisin as a multifunctional protein: implications for health and certain diseases. Medicina (Kaunas) 2019; 55(8): 485.
[http://dx.doi.org/10.3390/medicina55080485] [PMID: 31443222]
[35]
Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit β-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J Biol Chem 2013; 288(47): 33738-44.
[http://dx.doi.org/10.1074/jbc.M113.516641] [PMID: 24114836]
[36]
Ikeda K, Maretich P, Kajimura S. The common and distinct features of brown and beige adipocytes. Trends Endocrinol Metab 2018; 29(3): 191-200.
[http://dx.doi.org/10.1016/j.tem.2018.01.001] [PMID: 29366777]
[37]
Wang H, Willershäuser M, Karlas A, et al. A dual Ucp1 reporter mouse model for imaging and quantitation of brown and brite fat recruitment. Mol Metab 2019; 20: 14-27.
[http://dx.doi.org/10.1016/j.molmet.2018.11.009] [PMID: 30580967]
[38]
Hildebrand S, Stümer J, Pfeifer A. PVAT and its relation to brown, beige, and white adipose tissue in development and function. Front Physiol 2018; 9: 70.
[http://dx.doi.org/10.3389/fphys.2018.00070] [PMID: 29467675]
[39]
Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19(10): 1252-63.
[http://dx.doi.org/10.1038/nm.3361] [PMID: 24100998]
[40]
Giralt M, Villarroya F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology 2013; 154(9): 2992-3000.
[http://dx.doi.org/10.1210/en.2013-1403] [PMID: 23782940]
[41]
Sugiyama M, Shindo D, Kanada N, et al. Inducible brown/beige adipocytes in retro-orbital adipose tissues. Exp Eye Res 2019; 184: 8-14.
[http://dx.doi.org/10.1016/j.exer.2019.03.021] [PMID: 30946840]
[42]
Giordano A, Smorlesi A, Frontini A, Barbatelli G, Cinti S. White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol 2014; 170(5): R159-71.
[http://dx.doi.org/10.1530/EJE-13-0945] [PMID: 24468979]
[43]
Cinti S. Pink Adipocytes. Trends Endocrinol Metab 2018; 29(9): 651-66.
[http://dx.doi.org/10.1016/j.tem.2018.05.007] [PMID: 30017740]
[44]
Katzmarzyk PT, Powell KE, Jakicic JM, Troiano RP, Piercy K, Tennant B. sedentary behavior and health: update from the 2018 physical activity guidelines advisory committee. Med Sci Sports Exerc 2019; 51(6): 1227-41.
[http://dx.doi.org/10.1249/MSS.0000000000001935] [PMID: 31095080]
[45]
Zhou X, Xu M, Bryant JL, Ma J, Xu X. Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity. Cell Biosci 2019; 9(1): 32.
[http://dx.doi.org/10.1186/s13578-019-0294-y] [PMID: 30984367]
[46]
Krämer AI, Handschin C. How epigenetic modifications drive the expression and mediate the action of PGC-1α in the regulation of metabolism. Int J Mol Sci 2019; 20(21): 5449.
[http://dx.doi.org/10.3390/ijms20215449] [PMID: 31683747]
[47]
Leal LG, Lopes MA, Batista ML Jr. Jr Batista JrML. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases. Front Physiol 2018; 9: 1307.
[http://dx.doi.org/10.3389/fphys.2018.01307] [PMID: 30319436]
[48]
Fox J, Rioux BV, Goulet EDB, et al. Effect of an acute exercise bout on immediate post-exercise irisin concentration in adults: A meta-analysis. Scand J Med Sci Sports 2018; 28(1): 16-28.
[http://dx.doi.org/10.1111/sms.12904] [PMID: 28453881]
[49]
Colaianni G, Notarnicola A, Sanesi L, et al. Irisin levels correlate with bone mineral density in soccer players. J Biol Regul Homeost Agents 2017; 31(4)(Suppl. 1): 21-8.
[PMID: 29181953]
[50]
Huh JY, Siopi A, Mougios V, Park KH, Mantzoros CS. Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab 2015; 100(3): E453-7.
[http://dx.doi.org/10.1210/jc.2014-2416] [PMID: 25514098]
[51]
Kang YS, Kim JC, Kim JS, Kim SH. Effects of swimming exercise on serum irisin and bone FNDC5 in rat models of high-fat diet-induced osteoporosis. J Sports Sci Med 2019; 18(4): 596-603.
[PMID: 31827343]
[52]
Jia J, Yu F, Wei WP, et al. Relationship between circulating irisin levels and overweight/obesity: A meta-analysis. World J Clin Cases 2019; 7(12): 1444-55.
[http://dx.doi.org/10.12998/wjcc.v7.i12.1444] [PMID: 31363472]
[53]
Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf) 2015; 83(3): 339-43.
[http://dx.doi.org/10.1111/cen.12658] [PMID: 25382211]
[54]
Mai S, Grugni G, Mele C, et al. Irisin levels in genetic and essential obesity: clues for a potential dual role. Sci Rep 2020; 10(1): 1020.
[http://dx.doi.org/10.1038/s41598-020-57855-5] [PMID: 31974460]
[55]
Lombardi G, Ziemann E, Banfi G. Physical activity and bone health: what is the role of immune system? A narrative review of the third way. Front Endocrinol (Lausanne) 2019; 10: 60.
[http://dx.doi.org/10.3389/fendo.2019.00060] [PMID: 30792697]
[56]
Palermo A, Strollo R, Maddaloni E, et al. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf) 2015; 82(4): 615-9.
[http://dx.doi.org/10.1111/cen.12672] [PMID: 25400208]
[57]
Pullisaar H, Colaianni G, Lian AM, Vandevska-Radunovic V, Grano M, Reseland JE. Irisin promotes growth, migration and matrix formation in human periodontal ligament cells. Arch Oral Biol 2020; 111, 104635
[http://dx.doi.org/10.1016/j.archoralbio.2019.104635] [PMID: 31869727]
[58]
Perakakis N, Triantafyllou GA, Fernández-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol 2017; 13(6): 324-37.
[http://dx.doi.org/10.1038/nrendo.2016.221] [PMID: 28211512]
[59]
Cui L, Qiao T, Xu F, et al. Circulating irisin levels of prenatal and postnatal patients with gestational diabetes mellitus: A systematic review and meta-analysis. Cytokine 2020; 126, 154924
[http://dx.doi.org/10.1016/j.cyto.2019.154924] [PMID: 31864100]
[60]
Wang P, Ma HH, Hou XZ, Song LL, Song XL, Zhang JF. Reduced plasma level of irisin in first trimester as a risk factor for the development of gestational diabetes mellitus. Diabetes Res Clin Pract 2018; 142: 130-8.
[http://dx.doi.org/10.1016/j.diabres.2018.05.038] [PMID: 29852234]
[61]
Bozkaya D, Celik HT, Yigit S, Yurdakok M. Is serum irisin level lower in neonates born to mothers with gestational diabetes? Ann Med Res 2019; 26(7): 1264-7.
[http://dx.doi.org/10.5455/annalsmedres.2019.05.241]
[62]
Huang L, Yan S, Luo L, Yang L. Irisin regulates the expression of BDNF and glycometabolism in diabetic rats. Mol Med Rep 2019; 19(2): 1074-82.
[PMID: 30569121]
[63]
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-28.
[http://dx.doi.org/10.1016/S0140-6736(05)66378-7] [PMID: 15836891]
[64]
Cao RY, Zheng H, Redfearn D, Yang J. FNDC5: A novel player in metabolism and metabolic syndrome. Biochimie 2019; 158: 111-6.
[http://dx.doi.org/10.1016/j.biochi.2019.01.001] [PMID: 30611879]
[65]
Pedersen BK. Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol 2019; 15(7): 383-92.
[http://dx.doi.org/10.1038/s41574-019-0174-x] [PMID: 30837717]
[66]
Islam MR, Young MF, Wrann CD. The role of FNDC5/Irisin in the nervous system and as a mediator for beneficial effects of exercise on the brainHormones Metabolism and the Benefits of Exercise. Cham: Springer International Publishing 2017; pp. 93-102.
[http://dx.doi.org/10.1007/978-3-319-72790-5_8]
[67]
de Oliveira Bristot VJ, de Bem Alves AC, Cardoso LR, da Luz Scheffer D, Aguiar AS Jr. The role of PGC-1α/UCP2 signaling in the beneficial effects of physical exercise on the brain. Front Neurosci 2019; 13: 292.
[http://dx.doi.org/10.3389/fnins.2019.00292] [PMID: 30983964]
[68]
Kim OY, Song J. The role of irisin in Alzheimer’s disease. J Clin Med 2018; 7(11): 407.
[http://dx.doi.org/10.3390/jcm7110407] [PMID: 30388754]
[69]
Frame G, Bretland KA, Dengler-Crish CM. Mechanistic complexities of bone loss in Alzheimer’s disease: a review. Connect Tissue Res 2020; 61(1): 4-18.
[http://dx.doi.org/10.1080/03008207.2019.1624734] [PMID: 31184223]
[70]
Lourenco MV, Frozza RL, de Freitas GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med 2019; 25(1): 165-75.
[http://dx.doi.org/10.1038/s41591-018-0275-4] [PMID: 30617325]
[71]
Tari AR, Norevik CS, Scrimgeour NR, et al. Are the neuroprotective effects of exercise training systemically mediated? Prog Cardiovasc Dis 2019; 62(2): 94-101.
[http://dx.doi.org/10.1016/j.pcad.2019.02.003] [PMID: 30802460]
[72]
Guo P, Jin Z, Wu H, et al. Effects of irisin on the dysfunction of blood-brain barrier in rats after focal cerebral ischemia/reperfusion. Brain Behav 2019; 9(10) e01425
[http://dx.doi.org/10.1002/brb3.1425] [PMID: 31566928]
[73]
Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 2013; 18(5): 649-59.
[http://dx.doi.org/10.1016/j.cmet.2013.09.008] [PMID: 24120943]
[74]
Kim MH, Leem YH. The effects of peripherally-subacute treatment with irisin on hippocampal dendritogenesis and astrocyte-secreted factors. J Exerc Nutrition Biochem 2019; 23(4): 32-5.
[http://dx.doi.org/10.20463/jenb.2019.0029] [PMID: 32018344]
[75]
Li DJ, Li YH, Yuan HB, Qu LF, Wang P. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism 2017; 68: 31-42.
[http://dx.doi.org/10.1016/j.metabol.2016.12.003] [PMID: 28183451]
[76]
Young MF, Valaris S, Wrann CD. A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases. Prog Cardiovasc Dis 2019; 62(2): 172-8.
[http://dx.doi.org/10.1016/j.pcad.2019.02.007] [PMID: 30844383]
[77]
Tu T, Peng J, Jiang Y. FNDC5/Irisin: A New Protagonist in Acute Brain Injury. Stem Cells Dev 2020; 29(9): 533-43.
[http://dx.doi.org/10.1089/scd.2019.0232] [PMID: 31914844]
[78]
Belviranlı M, Okudan N. Exercise training protects against aging-induced cognitive dysfunction via activation of the hippocampal PGC-1α/FNDC5/BDNF pathway. Neuromolecular Med 2018; 20(3): 386-400.
[http://dx.doi.org/10.1007/s12017-018-8500-3] [PMID: 29971668]
[79]
Mazur-Bialy AI, Bilski J, Pochec E, Brzozowski T. New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes. Implication for exercise in obesity. J Physiol Pharmacol 2017; 68(2): 243-51.
[PMID: 28614774]
[80]
Mazur-Bialy AI. Irisin acts as a regulator of macrophages host defense. Life Sci 2017; 176: 21-5.
[http://dx.doi.org/10.1016/j.lfs.2017.03.011] [PMID: 28315350]
[81]
Mazur-Bialy AI, Pocheć E, Zarawski M. Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci 2017; 18(4) E701
[http://dx.doi.org/10.3390/ijms18040701] [PMID: 28346354]
[82]
Eslampour E, Ebrahimzadeh F, Abbasnezhad A, Khosroshahi MZ, Choghakhori R, Asbaghi O. Association between circulating irisin and C-Reactive protein levels: a systematic review and meta-analysis. Endocrinol Metab (Seoul) 2019; 34(2): 140-9.
[http://dx.doi.org/10.3803/EnM.2019.34.2.140] [PMID: 31257743]
[83]
Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 2020; 578(7796): 527-39.
[http://dx.doi.org/10.1038/s41586-020-2025-2] [PMID: 32103191]
[84]
Metzger C, Narayanan A, Zawieja D, Bloomfield S. Uses of irisin Patent WO2019084267A1 2019.
[85]
Gamal RM, Mohamed ME, Hammam N, El Fetoh NA, Rashed AM, Furst DE. Preliminary study of the association of serum irisin levels with poor sleep quality in rheumatoid arthritis patients. Sleep Med 2020; 67: 71-6.
[http://dx.doi.org/10.1016/j.sleep.2019.10.021] [PMID: 31918120]
[86]
Icli A, Cure E, Cumhur Cure M, et al. Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet’s disease. J Investig Med 2016; 64(4): 875-81.
[http://dx.doi.org/10.1136/jim-2015-000044] [PMID: 26941246]
[87]
Chen S, Wang L, Gao X, Chen M, Zeng Z, Zhao L. Characterization of serum irisin in patients with severe acute pancreatitis. Eur J Gastroenterol Hepatol 2019; 31(8): 985-91.
[http://dx.doi.org/10.1097/MEG.0000000000001454] [PMID: 31180990]
[88]
Ren YF, Wang MZ, Bi JB, et al. Irisin attenuates intestinal injury, oxidative and endoplasmic reticulum stress in mice with L-arginine-induced acute pancreatitis. World J Gastroenterol 2019; 25(45): 6653-67.
[http://dx.doi.org/10.3748/wjg.v25.i45.6653] [PMID: 31832004]
[89]
Bi J, Zhang J, Ren Y, et al. Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol 2019; 20: 296-306.
[http://dx.doi.org/10.1016/j.redox.2018.10.019] [PMID: 30388684]
[90]
Bi J, Yang L. Wang, T Irisin Improves Autophagy of aged hepatocytes via increasing telomerase activity in liver injury ox. Med Cell Longev 2020.
[91]
Matthews CE, Moore SC, Arem H, et al. Amount and intensity of leisure-time physical activity and lower cancer risk. J Clin Oncol 2020; 38(7): 686-97.
[http://dx.doi.org/10.1200/JCO.19.02407] [PMID: 31877085]
[92]
Sumsuzzman DM, Jin Y, Choi J, Yu JH, Lee TH, Hong Y. Pathophysiological role of endogenous irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic? Tumour Biol 2019; 41(12) 1010428319892790
[http://dx.doi.org/10.1177/1010428319892790] [PMID: 31815594]
[93]
Ko FH, Huang FT. Study the effect of irisin on prostate cancer cells FASEB J 2019.331 647: 16.
[94]
Nowinska K, Jablonska K, Pawelczyk K, et al. Expression of Irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer. Cancers (Basel) 2019; 11(10): 1538.
[http://dx.doi.org/10.3390/cancers11101538] [PMID: 31614634]
[95]
Zhang J, Ke M, Ren Y, et al. Serum irisin predicts posthepatectomy complications in patients with hepatocellular carcinoma. Dis Markers 2019; 2019, 9850191
[http://dx.doi.org/10.1155/2019/9850191] [PMID: 31976024]
[96]
Cheng G, Xu D, Chu K, Cao Z, Sun X, Yang Y. The effects of MiR-214-3p and Irisin/FNDC5 on the biological behavior of osteosarcoma cells. Cancer Biother Radiopharm 2020; 35(2): 92-100.
[http://dx.doi.org/10.1089/cbr.2019.2933] [PMID: 32073886]
[97]
Esawy MM, Abdel-Samd KM. The diagnostic and prognostic roles of serum irisin in bladder cancer. Curr Probl Cancer 2019.
[http://dx.doi.org/10.1016/j.currproblcancer.2019.100529]
[98]
Ugur K, Aydin S, Kuloglu T, et al. Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells. Cancer Manag Res 2019; 11: 2595-603.
[http://dx.doi.org/10.2147/CMAR.S201979] [PMID: 31114326]
[99]
Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer 2015; 136(4): E197-202.
[http://dx.doi.org/10.1002/ijc.29142] [PMID: 25124080]
[100]
Maalouf GE, El Khoury D. Exercise-induced irisin, the fat browning myokine, as a potential anticancer agent. J Obes 2019; 2019, 6561726
[http://dx.doi.org/10.1155/2019/6561726] [PMID: 31065382]
[101]
Wu H, Guo P, Jin Z, et al. Serum levels of irisin predict short-term outcomes in ischemic stroke. Cytokine 2019; 122, 154303
[http://dx.doi.org/10.1016/j.cyto.2018.02.017] [PMID: 29472066]
[102]
Ferreira J, Cunha P, Mansilha A. The role of the skeletal muscle in atherosclerosis. Angiol Cir Vasc 2019; 15(2): 65-70.
[103]
Zhang X, Hu C, Kong C-Y, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ 2020; 27(2): 540-55.
[http://dx.doi.org/10.1038/s41418-019-0372-z] [PMID: 31209361]
[104]
Öztürk G, Demirel O, Tekataş A. Circulating irisin levels in newly diagnosed obstructive sleep apnea patients. Scripta Scientifica Medica 2019; 51(1): 19-23.
[http://dx.doi.org/10.14748/ssm.v51i1.5908]
[105]
Guo X, Xuan X, Zhao B. Irisin in elderly people with hypertension, diabetes mellitus type 2, and overweight and obesity Int J Diab Develop Ctries 2020; 1-7.
[106]
Waluga M, Kukla M, Kotulski R, et al. Omentin, vaspin and irisin in chronic liver diseases. J Physiol Pharmacol 2019; 70(2): 277-85.
[PMID: 31443090]
[107]
Turgut B, Mercan K, Ilhan N. Serum irisin levels in chronic open-angle glaucoma. Adv Ophthalmol Vis Syst 2019; 9(6): 159-63.
[http://dx.doi.org/10.15406/aovs.2019.09.00370]
[108]
Chang CL, Huang SY, Hsu YC, Chin TH, Soong YK. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients. Sci Rep 2019; 9(1): 6447.
[http://dx.doi.org/10.1038/s41598-019-42061-9] [PMID: 31015585]
[109]
Foda AA, Foda EA, El-Said ZH. Serum irisin levels in polycystic ovary syndrome after ovarian drilling. Diabetes Metab Syndr 2019; 13(2): 1463-8.
[http://dx.doi.org/10.1016/j.dsx.2019.02.019] [PMID: 31336507]
[110]
Luo P, Zhang C, He Y, Yang G, Liu H, Li L. Several circulating biomarkers for PCOS diagnosis. Exp Clin Endocrinol Diabetes 2019.
[PMID: 31683329]
[111]
Tamma R, Colaianni G, Camerino C, et al. Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption. FASEB J 2009; 23(8): 2549-54.
[http://dx.doi.org/10.1096/fj.08-127951] [PMID: 19329761]
[112]
Gambacurta A, Merlini G, Ruggiero C, et al. Human osteogenic differentiation in Space: proteomic and epigenetic clues to better understand osteoporosis. Sci Rep 2019; 9(1): 8343.
[http://dx.doi.org/10.1038/s41598-019-44593-6] [PMID: 31171801]
[113]
Szumilewicz A, Worska A, Piernicka M. The exercise-induced irisin is associated with improved levels of glucose homeostasis markers in pregnant women participating in 8-week prenatal group fitness program: a pilot study. BioMed Res. Intern 2017.
[http://dx.doi.org/10.1155/2017/9414525]
[114]
Gonzalez-Gil AM, Peschard-Franco M, Castillo EC, et al. Myokine-adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome. Diabetol Metab Syndr 2019; 11: 63.
[http://dx.doi.org/10.1186/s13098-019-0458-2] [PMID: 31404407]
[115]
Yin C, Hu W, Wang M, Lv W, Jia T, Xiao Y. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents. Nutr Metab Cardiovasc Dis 2020; 30(2): 320-9.
[http://dx.doi.org/10.1016/j.numecd.2019.09.025] [PMID: 31740239]
[116]
Colaianni G, Faienza MF, Sanesi L, et al. Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatr Res 2019; 85(4): 484-8.
[http://dx.doi.org/10.1038/s41390-019-0278-y] [PMID: 30683930]
[117]
Seppä S, Tenhola S, Voutilainen R. Fibroblast growth factor 21, adiponectin, and irisin as markers of unfavorable metabolic features in 12-year-old children. J Endocr Soc 2019; 3(4): 825-37.
[http://dx.doi.org/10.1210/js.2018-00399] [PMID: 30963140]
[118]
Elizondo-Montemayor L, Gonzalez-Gil AM. Tamez-Rivera, O Association between irisin, hs-CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus. Med Inflamm 2019.
[119]
Ciresi A, Pizzolanti G, Guarnotta V, Giordano C. Circulating irisin levels in children with GH deficiency before and after 1 year of GH treatment. J Clin Endocrinol Metab 2019; 104(3): 801-8.
[http://dx.doi.org/10.1210/jc.2018-01440] [PMID: 30418584]
[120]
Cai L, Tan M, Tan W, et al. Associations of circulating irisin concentrations with cardiometabolic risk factors among children vary by physical activity or sedentary time levels. Front Endocrinol (Lausanne) 2019; 10: 549.
[http://dx.doi.org/10.3389/fendo.2019.00549] [PMID: 31474938]
[121]
Biddle SJ, Ciaccioni S, Thomas G, Vergeer I. Physical activity and mental health in children and adolescents: An updated review of reviews and an analysis of causality. Psychol Sport Exerc 2019; 42: 146-55.
[http://dx.doi.org/10.1016/j.psychsport.2018.08.011]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 1
ISSUE: 1
Year: 2020
Page: [32 - 41]
Pages: 10
DOI: 10.2174/2666796701999200617154655

Article Metrics

PDF: 27
HTML: 1